FDA Approves Wegovy injection to Lower risk of heart attack in Obese patients
The FDA has approved a new indication for Wegovy (semaglutide) injection to lower the risk of cardiovascular mortality, heart attack,
Read MoreThe FDA has approved a new indication for Wegovy (semaglutide) injection to lower the risk of cardiovascular mortality, heart attack,
Read MoreNew research suggests that individuals grappling with persistent and deteriorating metabolic syndrome — encompassing conditions like hypertension, elevated glycemia, surplus
Read MoreA new psychological treatment for children with epilepsy created by a UCL-led team of scientists has been shown to reduce
Read MoreIn a recent publication in BMC Public Health, researchers delved into potential connections between nutrient intake and multimorbidity. Background: Multimorbidity,
Read MoreNumerous biological factors influence the development and progression of type 2 diabetes, including the body’s insulin response, the health of
Read MoreMedical malpractice incidents manifest with increased severity during periods when daylight saving time is observed in the United States, as
Read MoreA new research report from Brigham and Women’s Hospital and collaborators suggests that menopause does not always increase the risk
Read MoreRecently, researchers conducted a comprehensive examination and meta-analysis to gain deeper insights into whether varying degrees of leisure time physical
Read MoreLactating mothers who receive the COVID-19 boosters pass the antibodies to their children through breast milk, potentially protecting babies who
Read MoreNew insights unveiled at this year’s European Congress on Obesity (ECO) in Venice, Italy (12-15 May) and disclosed in Diabetologia
Read More